Parmax Pharma Quarterly Results for Trading Insights
PARMAX • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-2 Cr
QMarch 2025
Parmax Pharma Quarterly Results Key Highlights
- Revenue of ₹28 Cr in March 2025 (+0.0% vs March 2025, +154.5% vs March 2024)
- Net Profit of ₹-2 Cr in March 2025 (+0.0% vs March 2025, +66.7% vs March 2024)
- Operating Margin of 1.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹-5.60 in March 2025 (+0.0% vs March 2025)
Parmax Pharma Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 16 | 28 | 11 | 16 | 18 | -42.9% | - |
| Net Profit (₹ Cr) | -5 | -2 | -6 | 0 | 0 | - | - |
| EBITDA (₹ Cr) | -3 | 0 | -3 | 2 | 3 | - | - |
| EPS (₹) | -12.70 | -5.60 | -34.56 | -0.28 | 0.38 | - | - |
| Operating Margin (%) | -27.0% | 1.0% | -31.0% | 15.0% | 14.0% | - | - |
Parmax Pharma Share Price Trend Around Quarterly Results
Visualize Parmax Pharma's 1-year price movement across quarterly results — ideal for logging trades in Parmax Pharma share price
chart using Tickjournal. All values in ₹.
Related Pages for Parmax Pharma
Additional stock information and data for PARMAX
Revenue Trend (₹ Cr)
March 2023
16
March 2024
11
March 2025
28
2026
16
Net Profit Trend (₹ Cr)
March 2023
0
March 2024
-6
March 2025
-2
2026
-5
Operating Margin Trend (%)
March 2023
15.0%
March 2024
-31.0%
March 2025
1.0%
2026
-27.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Parmax Pharma quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4092.2 | 3,219 | 591 | +11.3% | - | 18.4% | 233.3 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores